he Ascent merger offers access to an attractive client portfolio and adds substantially to PharmaLex?s global footprint, not only in the Japanese market but in other key markets throughout East and Southeast Asia. With deep roots in Asia, Ascent can act as a true partner in the region and, through the merger with PharmaLex
PharmaLex | 10/02/2022 | By Darshana | 790
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy